US3738370A - Method of defibrillating a malfunctioning heart by means of electrodes located within the atrium - Google Patents

Method of defibrillating a malfunctioning heart by means of electrodes located within the atrium Download PDF

Info

Publication number
US3738370A
US3738370A US00107312A US3738370DA US3738370A US 3738370 A US3738370 A US 3738370A US 00107312 A US00107312 A US 00107312A US 3738370D A US3738370D A US 3738370DA US 3738370 A US3738370 A US 3738370A
Authority
US
United States
Prior art keywords
atrium
heart
poles
impulses
cable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US00107312A
Inventor
B Charms
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of US3738370A publication Critical patent/US3738370A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/056Transvascular endocardial electrode systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/38Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
    • A61N1/39Heart defibrillators
    • A61N1/3956Implantable devices for applying electric shocks to the heart, e.g. for cardioversion

Definitions

  • ABSTRACT A bi-polar coaxial cable or catheter is passed transvenously into the right atrium or auricle of the heart, and the electrodes or poles of the cable are so positioned within the atrium and exposed to the interior of the atrium that when the cable is connected to a defibrillator unit, direct current shocks of very low energy or intensity may be transmitted by said unit through the cable to effect defibrillation, without causing pain or appreciable discomfort to the patient undergoing defibrillation.
  • the human heart beats about 70 times a minute, and while all of the fine mechanisms and forces that trigger the heartbeat are not known with precision, a small knot of tissue known as the pacemaker or sinus node is a vital spark plug. It is located in the upper part of the heart near where great veins enter the right auricle. It consists of specialized nerve and muscle cells which ignite a wave of muscle contraction in the heart. This wave spreads over auricular muscles and, although there is no direct connection, appears to travel from auricles to ventricles and muscles of the heart valves over a bridge, the auricular-ventricular or A-V node.
  • Atrial fibrillation For example, conversion of atrial fibrillation to normal rhythm by direct current countershock through the chest wall requires from 100 to 400 watt seconds of electrical energy, usually delivered very rapidly, i.e., for periods of 3-4 milliseconds.
  • a cardiac implantable demand Pacemaker consisting of a portable, self-contained device including circuitry which senses each natural heartbeat and resets the Pacemaker pulse generator timing in response to it.
  • This device stimulates only skipped beats and does not compete with natural beats, the first generated impulse after a natural beat occurring after a preset time interval longer than the natural interval unless another natural beat has intervened.
  • the Pacemaker timer is coordinated with it.
  • Atrial fibrillation found most often with rheumatic valvular disease (chiefly mitral stenosis), thyroid overactivity, or coronary disease with congestive failure, as well as a far more serious and often fatal disturbance of rhythm, known as ventricular fibrillation, in which condition the ventricle is not pumping, and which is rapidly fatal unless the heart can be defibrillated" by means of electrical machines which shock the heart out of its dangerous standstill.
  • ventricular fibrillation occurs most commonly in-acute coronary attacks, and during cardiac surgery, although it may unexpectedly occur during other forms of surgery.
  • small electrical impulses are delivered to the electrode, that is to say, impulses of the order of l to 5 milliamps at 6 volts, and at a frequency of 50 to 100 per minute.
  • Such impulses are effective to stimulate the ventricle to beat, but are far too small to be used with any useful effect for defibrillation.
  • the energy required for such a unit can be derived from an inductively rechargable battery source connected to a series of condenser plates for storage of the charge, as described, for automatic internal defibrillation.
  • the small energies required should permit miniaturization of the unit sufficient for practical permanent implantation in the body.
  • the cable could be interchangeably connected to a conventional pacer, so as to become usable for ordinary pacer purposes, thereby providing a complete control for all cardiac rhythm disturbances, whether too fast or too slow.
  • FIG. 1 is a cut-away view, somewhat diagrammatic in nature, showing the blood circulation of a normal heart, and showing, also, the manner in which the coaxial cable of the present invention is introduced into the right atrium or auricle of the heart, as well as the optimum or desired placement of the electrodes;
  • FIG. 2 is a cross-sectional view, on an enlarged scale, taken on the line 2-2 of FIG. 1;
  • FIG. 3 is a cross-sectional view, on an enlarged scale, taken on the line 33 of FIG. 1;
  • FIG. 4 is a cross-sectional view, on an enlarged scale, taken on the line 4-4 of FIG. 1.
  • reference numeral 1 designates the left atrium or auricle of the heart, 2, the left ventricle, 3, the right ventricle, 4, the right atrium or auricle, 5, the aorta, 6, the pulmonary artery, 7, the superior vena cava, and 8, the inferior vena cava.
  • a coaxial cable or catheter for purposes of effecting defibrillation, a coaxial cable or catheter, generally indicated by reference numeral 9, is used.
  • the coaxial cable consists of a lead wire 10, insulation 11 surrounding this lead wire, a tubular lead wire 12 surrounding the insulation 11, and a covering'insulation 13 surrounding the lead wire 12.
  • the wires and 12 may be made of any metal which has excellent electrical transmitting properties, and which is completely compatible with body fluids while the insulation 11 and 13 may be any electricallyinsulative inert material which has good insulating properties, such, for example, as Teflon, and which is also completely compatible with body fluids.
  • the cable 9 is passed transvenously through the body, and caused to enter the right atrium or auricle in the manner depicted in FIG. 1, that is to say, the leading portion of the cable is coiled within the atrium, so as to lie closely adjacent the inner wall or endocardium of the atrium. Before this is done, however, portions of the insulation are removed to expose the wire 10 at the point 100, and the wire 12 at the point 12a, these points thus becoming the electrodes or poles of the cable. These poles are, of course, completely insulated from each other.
  • poles or electrodes 10a and 120 are located at diametrically-opposite sides of the atrium, that is to say, at points which are at a maximum distance from each other diametrically of the atrium cavity or chamber.
  • the electrical countershock i.e., defibrillation shock
  • the poles or electrodes are located closer to each other,
  • shocks of greater intensity would have to be administered to effect the desired results.
  • the distance between the poles 10a and 12a will vary in accordance with the size of the atrium.
  • the inner and outer leads of the cable are then connected to a defibrillator machine or unit, indicated generally by reference numeral 14 in FIG. 1.
  • This unit is a source of direct current shocks of very low energy or intensity, i.e., from 1 to 10 watt seconds, and is so designed as to administer countershocks having a time duration of 3 to 50 milliseconds.
  • This time duration of the countershocks will depend on the thickness and qualities of the insulation provided in the cable, and, in some cases, countershocks up to milliseconds in duration can be used to successfully accomplish defibrillation while avoiding the problem of overall shock, to which reference has previously been made.
  • the defibrillator unit 14 may be a portable DC defibrillator unit, such as described in Druz U.S. Pat. No. 3,258,0I3, to which reference has been made. Synchronization may be effected by an automatic selector of the type described in the Tischler U.S. Pat. No. 3,135,264, which is designed for ratios too slow for the purposes of the present invention, but which can be adapted for ratios which are too fast. A unit such as described in the McLaughlin U.S. Pat. No. 3,527,228
  • a permanently-implantable self-contained power unit which could be set to determine the presence of a too-rapid or irregular heart beat and deliver a shock synchronized with the next intrinsic heart beat.
  • the energy required for suchv a unit can be derived from an inductively rechargable battery source connected to a series of condenser plates for storage of the charge.
  • any cable containing two wires in parallel spaced arrangement with each other, but fully insulated from each other, may be used, or, for that matter, insulated wires which are entirely separated from each other may be used, the important desideratum being the placement of the wire or wires in the atrium, and the spacing of the poles, electrodes or terminals of the wires in the atrium chamber or cavity.
  • I. In a method of defibrillating a malfunctioning heart, the steps of introducing a pair of electrical conductors transvenously into the right atrium of the heart, positioning said conductors within the atrium in widely spaced relation to each other, to thereby provide spaced poles located entirely within the atrium generating electrical impulses of an intensity of from 1 to 10 watt seconds sufficient to cause defibrillation of the heart, and delivering said impulses to said poles for a period of from 3 to 100 milliseconds.

Abstract

A bi-polar coaxial cable or catheter is passed transvenously into the right atrium or auricle of the heart, and the electrodes or poles of the cable are so positioned within the atrium and exposed to the interior of the atrium that when the cable is connected to a defibrillator unit, direct current shocks of very low energy or intensity may be transmitted by said unit through the cable to effect defibrillation, without causing pain or appreciable discomfort to the patient undergoing defibrillation.

Description

Charms METHOD OF DEFIBRILLATION WITH ELECTRODES LOCATED IN THE ATRIUM [76] Inventor: Bernard L. Charms, 2921 S. Park Boulevard, Shaker Heights, Ohio [22] Filed: Jan. 18, 1971 [2]] Appl. No.: 107,312
[521' U.S. C1 128/419 D [51] Int. Cl ..A61n 1/36 [58] FieldofSearch ..128/419 D,419 P,
[56] References Cited UNITED STATES PATENTS 3,664,347 5/1972 Harmjanz et al. 128/419 P 3,605,754 9/1971 Jaros et al 128/419 D 3,680,544 8/1972 Shinnick et al 128/419 P 3,144,019 8/1964 Haber 128/419 P 3,614,955 10/1971 Mirowski et al. 128/419 D [111 3,738,370 June 12, 1973 OTHER PUBLICATIONS Hopps et al., Surgery, Vol. 36, No.4, Oct. 1954, pp. 833-849 (only pp. 834 & 841 relied on) Primary ExaminerWilliam E. Kamm Atrorney-Isler & Omstein [57] ABSTRACT A bi-polar coaxial cable or catheter is passed transvenously into the right atrium or auricle of the heart, and the electrodes or poles of the cable are so positioned within the atrium and exposed to the interior of the atrium that when the cable is connected to a defibrillator unit, direct current shocks of very low energy or intensity may be transmitted by said unit through the cable to effect defibrillation, without causing pain or appreciable discomfort to the patient undergoing defibrillation.
7 Claims, 4 Drawing Figures DEFIBRILLATOR UNIT PATENIEBJUNIZIQB 3.738.370
/DEFIBRILLATOR UNIT INVENTOR.
BERNARD L. CHARMS Maw ATTORNEYS METHOD OF DEFIBRILLATION WITH ELECTRODES LOCATED IN THE ATRIUM The human heart beats about 70 times a minute, and while all of the fine mechanisms and forces that trigger the heartbeat are not known with precision, a small knot of tissue known as the pacemaker or sinus node is a vital spark plug. It is located in the upper part of the heart near where great veins enter the right auricle. It consists of specialized nerve and muscle cells which ignite a wave of muscle contraction in the heart. This wave spreads over auricular muscles and, although there is no direct connection, appears to travel from auricles to ventricles and muscles of the heart valves over a bridge, the auricular-ventricular or A-V node.
The electrical nature of impulses that spark the heartbeat is shown by the success of artificial pacers in triggering normal rhythms in some forms of heart disease. These artificial pacers are battery-powered devices, worn over the shoulder like a camera or implanted under the skin, which are connected to electrodes in heart tissue, and which feed tiny jolts of electric current to a faulty heart, to spark its beat and keep it running rhythmically.
An implantable cardiac Pacemaker is described in Greatbatch U.S. Pat. No. 3,057,356, this pacer permitting innocuous, painless, long term cardiac stimulation In U.S. Pat. No. 3,442,269, for example, reference is made to the fact that in closed chest utilization of the defibrillator, one of the electrodes is placed on the right border of the sternum just below the sternal notch, while the other electrode is placed on the midclavicular line near the fifth interspace, with the heart approximately midway therebetween, while for internal use, following thoracetomy, the electrodes may be applied directly across the heart itself.
Due to the high electrical resistance of the skin and other tissues between the heart muscle and the electrodes, and the distance of the electrodes from the heart, large or high electrical voltages are necessary to overcome this resistance. Shocks incident to the use of such high voltages, produce pain, and anesthesia is required to eliminate or lessen this pain, so that the shocks cannot be repeated at frequent intervals. Moreover, burns of the skin are frequently produced, and recurrence of the abnormal rhythm within a matter of weeks, is common.
For example, conversion of atrial fibrillation to normal rhythm by direct current countershock through the chest wall requires from 100 to 400 watt seconds of electrical energy, usually delivered very rapidly, i.e., for periods of 3-4 milliseconds.
In artificial pacers, to which reference has hereinbefore been made, it has been proposed, as in Chardack at low power levels by utilizing a small, completely implanted transistorized, battery operated Pacemaker, connected via flexible electrode wires directly to the myocardium or heart muscle. A subsequent Chardack U.S. Pat. No. 3,198,195, was an improvement, in that it taught variable Pacemaker controls, adjustable from outside the body by a percutaneous needle, to change Pacemaker rate and/or output level.
In a more recent Greatbatch U.S. Pat. No. 3,478,746, a cardiac implantable demand Pacemaker is described, consisting of a portable, self-contained device including circuitry which senses each natural heartbeat and resets the Pacemaker pulse generator timing in response to it. This device stimulates only skipped beats and does not compete with natural beats, the first generated impulse after a natural beat occurring after a preset time interval longer than the natural interval unless another natural beat has intervened. When a natural beat intervenes, the Pacemaker timer is coordinated with it.
Other irregularities of the heart beat, or arrhythmias, include atrial fibrillation, found most often with rheumatic valvular disease (chiefly mitral stenosis), thyroid overactivity, or coronary disease with congestive failure, as well as a far more serious and often fatal disturbance of rhythm, known as ventricular fibrillation, in which condition the ventricle is not pumping, and which is rapidly fatal unless the heart can be defibrillated" by means of electrical machines which shock the heart out of its dangerous standstill. Ventricular fibrillation occurs most commonly in-acute coronary attacks, and during cardiac surgery, although it may unexpectedly occur during other forms of surgery.
Such defibrillators are described, by way of example, in U.S. Pat. Nos. 3,211,154; 3,258,013; 3,389,704; 3,442,269; 3,454,012; 3,518,997 and 3,527,229.
The methods described in these patents and others, for the most part, employ electrical shocks applied to the external surface of the heart with the chest open, or through the'chest wall.
U.S. Pat. No. 3,348,548, to provide an implantable bipolar electrode which is inserted through a vein, one of the jugular veins, for example, and brought to lie in contact with the inner lining of the heart. However, in such a pacer, in common with all pacers, small electrical impulses are delivered to the electrode, that is to say, impulses of the order of l to 5 milliamps at 6 volts, and at a frequency of 50 to 100 per minute. Such impulses are effective to stimulate the ventricle to beat, but are far too small to be used with any useful effect for defibrillation.
I have discovered that by proper placement of a bipolar coaxial cable, of novel or unique construction, in the right atrium, and inserted transvenously, as through the jugular vein, I can quickly convert a rapid irregular rhythm to a normal rhythm, by the administration of direct current shocks, of the same duration as those delivered through the chest wall, but of very low energy or intensity, i.e., 1 to 10 watt seconds.
I have further found that the closer the two electrodes are to each other, the greater the electrical energy that is required to accomplish the defibrillation, and that the distance between the two electrodes should ideally be that equivalent to one-half the circumference of the right atrium.
I have further noted that a the delivery time or period of 3-4 milliseconds, sufficient insulation for the bipolar coaxial cable to prevent shocking the body generally must be provided, because the voltage and amperage levels required may reach 1,000 volts and amperes. However, as previously shown by others, successful defibrillation by countershock, up to milliseconds in duration can be accomplished. With the longer duration, lower voltages and amperages can be used, avoiding the problem of overall shocks, and reducing the requirements for insulation. This also makes possible the permanent implantation of a self-contained power unit attached to the cable positioned in the right atrium. Such a unit could be set to determine the presence of a too rapid or irregular heart rate and deliver a shock synchronized with the next intrinsic heart beat. The energy required for such a unit can be derived from an inductively rechargable battery source connected to a series of condenser plates for storage of the charge, as described, for automatic internal defibrillation. The small energies required should permit miniaturization of the unit sufficient for practical permanent implantation in the body. Moreover, the cable could be interchangeably connected to a conventional pacer, so as to become usable for ordinary pacer purposes, thereby providing a complete control for all cardiac rhythm disturbances, whether too fast or too slow.
The invention may be explained with reference to the accompanying drawings, wherein FIG. 1 is a cut-away view, somewhat diagrammatic in nature, showing the blood circulation of a normal heart, and showing, also, the manner in which the coaxial cable of the present invention is introduced into the right atrium or auricle of the heart, as well as the optimum or desired placement of the electrodes;
FIG. 2 is a cross-sectional view, on an enlarged scale, taken on the line 2-2 of FIG. 1;
FIG. 3 is a cross-sectional view, on an enlarged scale, taken on the line 33 of FIG. 1; and
FIG. 4 is a cross-sectional view, on an enlarged scale, taken on the line 4-4 of FIG. 1.
Referring more particularly to the drawings, reference numeral 1 designates the left atrium or auricle of the heart, 2, the left ventricle, 3, the right ventricle, 4, the right atrium or auricle, 5, the aorta, 6, the pulmonary artery, 7, the superior vena cava, and 8, the inferior vena cava.
For purposes of effecting defibrillation, a coaxial cable or catheter, generally indicated by reference numeral 9, is used.
The coaxial cable consists of a lead wire 10, insulation 11 surrounding this lead wire, a tubular lead wire 12 surrounding the insulation 11, and a covering'insulation 13 surrounding the lead wire 12.
The wires and 12 may be made of any metal which has excellent electrical transmitting properties, and which is completely compatible with body fluids while the insulation 11 and 13 may be any electricallyinsulative inert material which has good insulating properties, such, for example, as Teflon, and which is also completely compatible with body fluids.
The cable 9 is passed transvenously through the body, and caused to enter the right atrium or auricle in the manner depicted in FIG. 1, that is to say, the leading portion of the cable is coiled within the atrium, so as to lie closely adjacent the inner wall or endocardium of the atrium. Before this is done, however, portions of the insulation are removed to expose the wire 10 at the point 100, and the wire 12 at the point 12a, these points thus becoming the electrodes or poles of the cable. These poles are, of course, completely insulated from each other.
It is to be noted that the poles or electrodes 10a and 120 are located at diametrically-opposite sides of the atrium, that is to say, at points which are at a maximum distance from each other diametrically of the atrium cavity or chamber. With the poles or electrodes thus positioned, the electrical countershock, i.e., defibrillation shock, passed between the poles or electrodes, traverses the entire atrium, and exerts a maximum defibrillatory action, covering the entire chamber wall. If
the poles or electrodes are located closer to each other,
shocks of greater intensity would have to be administered to effect the desired results.
The distance between the poles 10a and 12a will vary in accordance with the size of the atrium.
The inner and outer leads of the cable are then connected to a defibrillator machine or unit, indicated generally by reference numeral 14 in FIG. 1. This unit is a source of direct current shocks of very low energy or intensity, i.e., from 1 to 10 watt seconds, and is so designed as to administer countershocks having a time duration of 3 to 50 milliseconds.
This time duration of the countershocks will depend on the thickness and qualities of the insulation provided in the cable, and, in some cases, countershocks up to milliseconds in duration can be used to successfully accomplish defibrillation while avoiding the problem of overall shock, to which reference has previously been made.
The defibrillator unit 14 may be a portable DC defibrillator unit, such as described in Druz U.S. Pat. No. 3,258,0I3, to which reference has been made. Synchronization may be effected by an automatic selector of the type described in the Tischler U.S. Pat. No. 3,135,264, which is designed for ratios too slow for the purposes of the present invention, but which can be adapted for ratios which are too fast. A unit such as described in the McLaughlin U.S. Pat. No. 3,527,228
could also be adapted for use in the present invention, and a synchronizer such as described in the Berkovits U.S. Pat. No. 3,345,990 could be adapted to show R-R intervals. In this connection, the curves shown in FIGS. 2a, 2b, 2c, 2d and 3 of the above Druz patent are of interest.
By reducing the requirements for insulation, it becomes possible to utilize a permanently-implantable self-contained power unit, which could be set to determine the presence of a too-rapid or irregular heart beat and deliver a shock synchronized with the next intrinsic heart beat. The energy required for suchv a unit can be derived from an inductively rechargable battery source connected to a series of condenser plates for storage of the charge.
Although the invention has been described with particular reference to the use of a bi-polar coaxial cable, it is to be understood that any cable containing two wires in parallel spaced arrangement with each other, but fully insulated from each other, may be used, or, for that matter, insulated wires which are entirely separated from each other may be used, the important desideratum being the placement of the wire or wires in the atrium, and the spacing of the poles, electrodes or terminals of the wires in the atrium chamber or cavity.
It is to be understood that various changes in the method and apparatus which has been described may be made without departing from the spirit of the invention and the scope of the appended claims.
Having thus described my invention, 1 claim:
I. In a method of defibrillating a malfunctioning heart, the steps of introducing a pair of electrical conductors transvenously into the right atrium of the heart, positioning said conductors within the atrium in widely spaced relation to each other, to thereby provide spaced poles located entirely within the atrium generating electrical impulses of an intensity of from 1 to 10 watt seconds sufficient to cause defibrillation of the heart, and delivering said impulses to said poles for a period of from 3 to 100 milliseconds.
of the body of the person who is being defibrillated.
6. The method, as defined in claim 1, wherein said electrical impulses or shocks are generated within the body of the person who is being defibrillated.
7. The method, as recited in claim 1, wherein said placement of the poles is effected by coiling the leading portions of said conductors about the atrium in closely spaced relation to the inner wall of the atrium.

Claims (7)

1. In a method of defibrillating a malfunctioning heart, the steps of introducing a pair of electrical conductors transvenously into the right atrium of the heart, positioning said conductors within the atrium in widely spaced relation to each other, to thereby provide spaced poles located entirely within the atrium generating electrical impulses of an intensity of from 1 to 10 watt seconds sufficient to cause defibrillation of the heart, and delivering said impulses to said poles for a period of from 3 to 100 milliseconds.
2. The method, as defined in claim 1, wherein said poles are disposed adjacent the wall of the atrium.
3. The method, as defined in claim 1, wherein said poles are disposed at diametrically-opposite sides of the atrium.
4. The method, as defined in claim 1, wherein said impulses are direct current impulses.
5. The method, as defined in claim 1, wherein said electrical impulses or shocks are generated externally of the body of the person who is being defibrillated.
6. The method, as defined in claim 1, wherein said electrical impulses or shocks are generated within the body of the person who is being defibrillated.
7. The method, as recited in claim 1, wherein Said placement of the poles is effected by coiling the leading portions of said conductors about the atrium in closely spaced relation to the inner wall of the atrium.
US00107312A 1971-01-18 1971-01-18 Method of defibrillating a malfunctioning heart by means of electrodes located within the atrium Expired - Lifetime US3738370A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10731271A 1971-01-18 1971-01-18

Publications (1)

Publication Number Publication Date
US3738370A true US3738370A (en) 1973-06-12

Family

ID=22315989

Family Applications (1)

Application Number Title Priority Date Filing Date
US00107312A Expired - Lifetime US3738370A (en) 1971-01-18 1971-01-18 Method of defibrillating a malfunctioning heart by means of electrodes located within the atrium

Country Status (1)

Country Link
US (1) US3738370A (en)

Cited By (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3866615A (en) * 1973-01-15 1975-02-18 Daigle Claude W Portable electronic cardiac stimulator
US3942536A (en) * 1971-03-15 1976-03-09 Mieczyslaw Mirowski Cardioverting device having single intravascular catheter electrode system and method for its use
US3952750A (en) * 1974-04-25 1976-04-27 Mieczyslaw Mirowski Command atrial cardioverting device
EP0023134A1 (en) * 1979-07-19 1981-01-28 Medtronic, Inc. Implantable cardioverter
EP0060117A2 (en) * 1981-03-06 1982-09-15 Medtronic, Inc. Synchronized intracardiac cardioverter
FR2528708A1 (en) * 1982-06-18 1983-12-23 Mirowski Mieczyslaw METHOD AND APPARATUS FOR CORRECTING ABNORMAL CARDIAC ACTIVITY BY LOW ENERGY SHOCK
US4572191A (en) * 1974-04-25 1986-02-25 Mieczyslaw Mirowski Command atrial cardioverter
US4834100A (en) * 1986-05-12 1989-05-30 Charms Bernard L Apparatus and method of defibrillation
DE3914662A1 (en) * 1989-05-03 1990-11-08 Alt Eckhard DEVICE FOR TRANSMITTING ELECTRICAL SIGNALS BETWEEN AN IMPLANTABLE MEDICAL DEVICE AND ELECTRICALLY EXPENSIBLE HUMAN TISSUE
US4991578A (en) * 1989-04-04 1991-02-12 Siemens-Pacesetter, Inc. Method and system for implanting self-anchoring epicardial defibrillation electrodes
US5188105A (en) * 1990-11-14 1993-02-23 Medtronic, Inc. Apparatus and method for treating a tachyarrhythmia
US5193536A (en) * 1990-12-20 1993-03-16 Medtronic, Inc. Paced cardioversion
US5207219A (en) * 1992-10-23 1993-05-04 Incontrol, Inc. Atrial defibrillator and method for providing interval timing prior to cardioversion
US5265600A (en) * 1992-10-23 1993-11-30 Incontrol, Inc. Atrial defibrillator and method for providing post-cardioversion pacing
US5267559A (en) * 1992-10-23 1993-12-07 Incontrol, Inc. Atrial defibrillator and method for providing atrial sensing
US5269298A (en) * 1992-10-23 1993-12-14 Incontrol, Inc. Atrial defibrillator and method for providing synchronized delayed cardioversion
US5279291A (en) * 1991-04-12 1994-01-18 Incontrol, Inc. Method for atrial defibrillation
US5282836A (en) * 1992-10-23 1994-02-01 Incontrol, Inc. Atrial defibrillator and method for providing pre-cardioversion pacing
US5292338A (en) * 1992-07-30 1994-03-08 Medtronic, Inc. Atrial defibrillator employing transvenous and subcutaneous electrodes and method of use
US5314430A (en) * 1993-06-24 1994-05-24 Medtronic, Inc. Atrial defibrillator employing transvenous and subcutaneous electrodes and method of use
US5391185A (en) * 1993-02-22 1995-02-21 Angeion Corporation Atrial cardioverter with ventricular protection
US5439481A (en) * 1992-02-26 1995-08-08 Angeion Corporation Semi-automatic atrial and ventricular cardioverter defibrillator
US5486198A (en) * 1994-08-12 1996-01-23 Ayers; Gregory M. Atrial defibrillator and method for providing interval timing of successive intervals prior to cardioversion
US5549642A (en) * 1994-08-19 1996-08-27 Medtronic, Inc. Atrial defibrillator and method of use
US5630834A (en) * 1995-05-03 1997-05-20 Medtronic, Inc. Atrial defibrillator with means for delivering therapy in response to a determination that the patient is likely asleep
US5690686A (en) * 1996-04-30 1997-11-25 Medtronic, Inc. Atrial defibrillation method
WO1999051302A1 (en) 1998-04-03 1999-10-14 Medtronic, Inc. Defibrillator having electrolytic capacitor with cold-welded electrode layers
WO1999051301A1 (en) 1998-04-03 1999-10-14 Medtronic, Inc. Implantable device having flat multilayered electrolytic capacitor
WO1999051303A1 (en) 1998-04-03 1999-10-14 Medtronic, Inc. Method of making a defibrillator having a flat electrolytic capacitor
WO1999066985A1 (en) 1998-06-24 1999-12-29 Medtronic, Inc. Implantable medical device having flat electrolytic capacitor with consolidated electrode tabs and corresponding feedthroughs
US6091989A (en) * 1998-04-08 2000-07-18 Swerdlow; Charles D. Method and apparatus for reduction of pain from electric shock therapies
EP1053763A2 (en) 1999-03-23 2000-11-22 Medtronic, Inc. Implantable medical device having a capacitor assembly with liner
US6445948B1 (en) 1998-04-03 2002-09-03 Medtronic, Inc. Implantable medical device having a substantially flat battery
US6459566B1 (en) 1998-06-24 2002-10-01 Medtronic, Inc. Implantable medical device having flat electrolytic capacitor with laser welded cover
US6574505B1 (en) 1997-08-08 2003-06-03 Cardiac Pacemakers, Inc. Atrial and ventricular implantable cardioverter-defibrillator and lead system
US7027861B2 (en) 2001-10-09 2006-04-11 Medtronic, Inc. Method and apparatus for affecting atrial defibrillation with bi-atrial pacing
US20060161206A1 (en) * 2004-11-04 2006-07-20 Efimov Igor R Method for low-voltage termination of cardiac arrhythmias by effectively unpinning anatomical reentries
US20090204164A1 (en) * 2007-12-11 2009-08-13 Efimov Igor R Method and device for low-energy termination of atrial tachyarrhythmias
US20100016917A1 (en) * 2006-11-13 2010-01-21 Washington University In St. Louis Cardiac pacing using the inferior nodal extension
WO2011139596A2 (en) 2010-05-07 2011-11-10 The Washington University Method and device for three-stage atrial cardioversion therapy
US8473051B1 (en) 2010-12-29 2013-06-25 Cardialen, Inc. Low-energy atrial cardioversion therapy with controllable pulse-shaped waveforms
US8874208B2 (en) 2007-12-11 2014-10-28 The Washington University Methods and devices for three-stage ventricular therapy
US9636504B2 (en) 2012-12-11 2017-05-02 Galvani, Ltd. Arrhythmia electrotheraphy device and method with provisions for mitigating patient discomfort
US10905884B2 (en) 2012-07-20 2021-02-02 Cardialen, Inc. Multi-stage atrial cardioversion therapy leads

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3144019A (en) * 1960-08-08 1964-08-11 Haber Edgar Cardiac monitoring device
US3605754A (en) * 1967-11-23 1971-09-20 South African Inventions Double pulse heart defibrillator and method of use
US3614955A (en) * 1970-02-09 1971-10-26 Medtronic Inc Standby defibrillator and method of operation
US3664347A (en) * 1968-07-27 1972-05-23 Dietrich Harmjanz Electric heart stimulation method and electrode
US3680544A (en) * 1970-09-09 1972-08-01 James P Shinnick Transthoracic cannula-type device for cardiopulmonary resuscitation

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3144019A (en) * 1960-08-08 1964-08-11 Haber Edgar Cardiac monitoring device
US3605754A (en) * 1967-11-23 1971-09-20 South African Inventions Double pulse heart defibrillator and method of use
US3664347A (en) * 1968-07-27 1972-05-23 Dietrich Harmjanz Electric heart stimulation method and electrode
US3614955A (en) * 1970-02-09 1971-10-26 Medtronic Inc Standby defibrillator and method of operation
US3680544A (en) * 1970-09-09 1972-08-01 James P Shinnick Transthoracic cannula-type device for cardiopulmonary resuscitation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Hopps et al., Surgery , Vol. 36, No. 4, Oct. 1954, pp. 833 849 (only pp. 834 & 841 relied on) *

Cited By (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3942536A (en) * 1971-03-15 1976-03-09 Mieczyslaw Mirowski Cardioverting device having single intravascular catheter electrode system and method for its use
US3866615A (en) * 1973-01-15 1975-02-18 Daigle Claude W Portable electronic cardiac stimulator
US4572191A (en) * 1974-04-25 1986-02-25 Mieczyslaw Mirowski Command atrial cardioverter
US3952750A (en) * 1974-04-25 1976-04-27 Mieczyslaw Mirowski Command atrial cardioverting device
EP0023134A1 (en) * 1979-07-19 1981-01-28 Medtronic, Inc. Implantable cardioverter
EP0060117A2 (en) * 1981-03-06 1982-09-15 Medtronic, Inc. Synchronized intracardiac cardioverter
EP0060117A3 (en) * 1981-03-06 1983-03-23 Medtronic, Inc. Synchronized intracardiac cardioverter
FR2528708A1 (en) * 1982-06-18 1983-12-23 Mirowski Mieczyslaw METHOD AND APPARATUS FOR CORRECTING ABNORMAL CARDIAC ACTIVITY BY LOW ENERGY SHOCK
NL8302182A (en) * 1982-06-18 1984-01-16 Mirowski Mieczyslaw TRANSFORMER.
US4834100A (en) * 1986-05-12 1989-05-30 Charms Bernard L Apparatus and method of defibrillation
EP0392099A1 (en) * 1986-05-12 1990-10-17 Bernard L. Charms Defibrillation apparatus
US4991578A (en) * 1989-04-04 1991-02-12 Siemens-Pacesetter, Inc. Method and system for implanting self-anchoring epicardial defibrillation electrodes
DE3914662A1 (en) * 1989-05-03 1990-11-08 Alt Eckhard DEVICE FOR TRANSMITTING ELECTRICAL SIGNALS BETWEEN AN IMPLANTABLE MEDICAL DEVICE AND ELECTRICALLY EXPENSIBLE HUMAN TISSUE
US5188105A (en) * 1990-11-14 1993-02-23 Medtronic, Inc. Apparatus and method for treating a tachyarrhythmia
US5193536A (en) * 1990-12-20 1993-03-16 Medtronic, Inc. Paced cardioversion
US5279291A (en) * 1991-04-12 1994-01-18 Incontrol, Inc. Method for atrial defibrillation
US5439481A (en) * 1992-02-26 1995-08-08 Angeion Corporation Semi-automatic atrial and ventricular cardioverter defibrillator
US5292338A (en) * 1992-07-30 1994-03-08 Medtronic, Inc. Atrial defibrillator employing transvenous and subcutaneous electrodes and method of use
US5269298A (en) * 1992-10-23 1993-12-14 Incontrol, Inc. Atrial defibrillator and method for providing synchronized delayed cardioversion
US5207219A (en) * 1992-10-23 1993-05-04 Incontrol, Inc. Atrial defibrillator and method for providing interval timing prior to cardioversion
US5282836A (en) * 1992-10-23 1994-02-01 Incontrol, Inc. Atrial defibrillator and method for providing pre-cardioversion pacing
US5267559A (en) * 1992-10-23 1993-12-07 Incontrol, Inc. Atrial defibrillator and method for providing atrial sensing
EP0594269A2 (en) * 1992-10-23 1994-04-27 Incontrol, Inc. Atrial defibrillator and method for providing interval timing prior to cardioversion
EP0594269A3 (en) * 1992-10-23 1994-12-21 Incontrol Inc Atrial defibrillator and method for providing interval timing prior to cardioversion.
US5265600A (en) * 1992-10-23 1993-11-30 Incontrol, Inc. Atrial defibrillator and method for providing post-cardioversion pacing
US5391185A (en) * 1993-02-22 1995-02-21 Angeion Corporation Atrial cardioverter with ventricular protection
US5314430A (en) * 1993-06-24 1994-05-24 Medtronic, Inc. Atrial defibrillator employing transvenous and subcutaneous electrodes and method of use
US5486198A (en) * 1994-08-12 1996-01-23 Ayers; Gregory M. Atrial defibrillator and method for providing interval timing of successive intervals prior to cardioversion
US5549642A (en) * 1994-08-19 1996-08-27 Medtronic, Inc. Atrial defibrillator and method of use
US5630834A (en) * 1995-05-03 1997-05-20 Medtronic, Inc. Atrial defibrillator with means for delivering therapy in response to a determination that the patient is likely asleep
US5690686A (en) * 1996-04-30 1997-11-25 Medtronic, Inc. Atrial defibrillation method
US20060247689A1 (en) * 1997-08-08 2006-11-02 Cardiac Pacemakers, Inc. Atrial and ventricular implantable cardioverter-defibrillator and lead system
US7103409B2 (en) 1997-08-08 2006-09-05 Cardiac Pacemakers, Inc. Atrial and ventricular implantable cardioverter-defibrillator and lead system
US20030195576A1 (en) * 1997-08-08 2003-10-16 Cardiac Pacemakers, Inc. Atrial and ventricular implantable cardioverter-defibrillator and lead system
US6574505B1 (en) 1997-08-08 2003-06-03 Cardiac Pacemakers, Inc. Atrial and ventricular implantable cardioverter-defibrillator and lead system
WO1999051302A1 (en) 1998-04-03 1999-10-14 Medtronic, Inc. Defibrillator having electrolytic capacitor with cold-welded electrode layers
WO1999051301A1 (en) 1998-04-03 1999-10-14 Medtronic, Inc. Implantable device having flat multilayered electrolytic capacitor
WO1999051303A1 (en) 1998-04-03 1999-10-14 Medtronic, Inc. Method of making a defibrillator having a flat electrolytic capacitor
US6445948B1 (en) 1998-04-03 2002-09-03 Medtronic, Inc. Implantable medical device having a substantially flat battery
US6438418B1 (en) 1998-04-08 2002-08-20 Imperception, Incorporated Method and apparatus for reduction of pain from electric shock therapies
US6091989A (en) * 1998-04-08 2000-07-18 Swerdlow; Charles D. Method and apparatus for reduction of pain from electric shock therapies
US6459566B1 (en) 1998-06-24 2002-10-01 Medtronic, Inc. Implantable medical device having flat electrolytic capacitor with laser welded cover
WO1999066985A1 (en) 1998-06-24 1999-12-29 Medtronic, Inc. Implantable medical device having flat electrolytic capacitor with consolidated electrode tabs and corresponding feedthroughs
EP1053763A2 (en) 1999-03-23 2000-11-22 Medtronic, Inc. Implantable medical device having a capacitor assembly with liner
US6678559B1 (en) 1999-03-23 2004-01-13 Medtronic, Inc. Implantable medical device having a capacitor assembly with liner
US7027861B2 (en) 2001-10-09 2006-04-11 Medtronic, Inc. Method and apparatus for affecting atrial defibrillation with bi-atrial pacing
US20060161206A1 (en) * 2004-11-04 2006-07-20 Efimov Igor R Method for low-voltage termination of cardiac arrhythmias by effectively unpinning anatomical reentries
US11191474B2 (en) 2004-11-04 2021-12-07 Washington University Method for low-voltage termination of cardiac arrhythmias by effectively unpinning anatomical reentries
US8639325B2 (en) 2004-11-04 2014-01-28 Washington University Method for low-voltage termination of cardiac arrhythmias by effectively unpinning anatomical reentries
US10549108B2 (en) 2004-11-04 2020-02-04 The Washington University Method for low-voltage termination of cardiac arrhythmias by effectively unpinning anatomical reentries
US8175702B2 (en) 2004-11-04 2012-05-08 The Washington University Method for low-voltage termination of cardiac arrhythmias by effectively unpinning anatomical reentries
US10071257B2 (en) 2004-11-04 2018-09-11 Washington University Method for low-voltage termination of cardiac arrhythmias by effectively unpinning anatomical reentries
US9586055B2 (en) 2004-11-04 2017-03-07 Washington University Method for low-voltage termination of cardiac arrhythmias by effectively unpinning anatomical reentries
US9067079B2 (en) 2004-11-04 2015-06-30 Washington University Method for low-voltage termination of cardiac arrhythmias by effectively unpinning anatomical reentries
US20100016917A1 (en) * 2006-11-13 2010-01-21 Washington University In St. Louis Cardiac pacing using the inferior nodal extension
US8391995B2 (en) 2006-11-13 2013-03-05 The Washington University Cardiac pacing using the inferior nodal extension
US10099062B2 (en) 2007-12-11 2018-10-16 Washington University Methods and devices for multi-stage ventricular therapy
US9814895B2 (en) 2007-12-11 2017-11-14 The Washington University Method and device for three-stage atrial cardioversion therapy
US8706216B2 (en) 2007-12-11 2014-04-22 The Washington University Method and device for three-stage atrial cardioversion therapy
US9289620B2 (en) 2007-12-11 2016-03-22 The Washington University Method and device for three-stage atrial cardioversion therapy
US9526907B2 (en) 2007-12-11 2016-12-27 Washington University Methods and devices for multi-stage ventricular therapy
US8874208B2 (en) 2007-12-11 2014-10-28 The Washington University Methods and devices for three-stage ventricular therapy
US8560066B2 (en) 2007-12-11 2013-10-15 Washington University Method and device for three-stage atrial cardioversion therapy
US11083905B2 (en) 2007-12-11 2021-08-10 The Washington University Methods and devices for ventricular therapy
US8509889B2 (en) 2007-12-11 2013-08-13 Washington University Method and device for low-energy termination of atrial tachyarrhythmias
US20090204164A1 (en) * 2007-12-11 2009-08-13 Efimov Igor R Method and device for low-energy termination of atrial tachyarrhythmias
US10413741B2 (en) 2007-12-11 2019-09-17 The Washington University Methods and devices for multi-stage ventricular therapy
US11097120B2 (en) 2007-12-11 2021-08-24 The Washington University Method and device for atrial cardioversion therapy
US10441805B2 (en) 2007-12-11 2019-10-15 The Washington University Method and device for three-stage atrial cardioversion therapy
WO2011139596A2 (en) 2010-05-07 2011-11-10 The Washington University Method and device for three-stage atrial cardioversion therapy
US8473051B1 (en) 2010-12-29 2013-06-25 Cardialen, Inc. Low-energy atrial cardioversion therapy with controllable pulse-shaped waveforms
US10905884B2 (en) 2012-07-20 2021-02-02 Cardialen, Inc. Multi-stage atrial cardioversion therapy leads
US11918816B2 (en) 2012-07-20 2024-03-05 Maxwell Biomedical Inc. Multi-stage atrial cardioversion therapy leads
US10143851B2 (en) 2012-12-11 2018-12-04 Galvani, Ltd. Arrhythmia electrotherapy device and method with provisions for mitigating patient discomfort
US9636504B2 (en) 2012-12-11 2017-05-02 Galvani, Ltd. Arrhythmia electrotheraphy device and method with provisions for mitigating patient discomfort

Similar Documents

Publication Publication Date Title
US3738370A (en) Method of defibrillating a malfunctioning heart by means of electrodes located within the atrium
JP4267912B2 (en) Subcutaneous implantable and integrated defibrillator
US5928270A (en) Method and apparatus for incremental cardioversion or defibrillation
US5735876A (en) Electrical cardiac output forcing method and apparatus for an atrial defibrillator
US11083904B2 (en) Bisphasic or multiphasic pulse waveform and method
US7463924B2 (en) Methods for determining placement of an implantable cardiac stimulus device
US8718760B2 (en) Subcutaneous implantable cardioverter-defibrillator placement methods
US5282843A (en) Electrodes and method for transcutaneous cardiac pacing
EP1318856B1 (en) Subcutaneous only implantable cardioverter-defibrillator and optional pacer
US5782883A (en) Suboptimal output device to manage cardiac tachyarrhythmias
US6330475B1 (en) System and a corresponding method for treating defibrillation in a heart
US5683429A (en) Method and apparatus for cardiac pacing to prevent atrial fibrillation
US8014862B2 (en) Anterior active housing subcutaneous positioning methods
EP0281219B1 (en) Cardiac defibrillator
US20080086175A1 (en) Method and apparatus for reducing defibrillation threshold
JPH02307482A (en) Catheter type lead wire for intravena
ZOLL et al. External and internal electric cardiac pacemakers
WO2008005386A2 (en) Devices, systems and methods for pacing, resynchronization and defibrillation therapy
Zuckerman et al. Clinical experiences with a new implantable demand pacemaker
Zoll Development of electric control of cardiac rhythm
Zoll Historical development of cardiac pacemakers
Hopps Cardiac Resuscitation—The Present Status of Defibrillation and Stimulation Techniques
ZOLL Clinical Progress
JPH01288273A (en) Intravenous catheter type lead wire
Zipes et al. Pacing and transvenous cardioversion to control tachyarrhythmias